Product Details
Nat-Lanthanum
Lanthanum500 mg
Chewable Tablet
DIN/PIN/NPN
02498758
Manufacturer
Natco Pharma (Canada) Inc.
Formulary Listing Date
2020-07-31
Unit Price
2.4069
Amount MOH Pays
2.4068
Coverage Status
Off-Formulary Interchangeable Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
V03AE03
Interchangeable Products
DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
---|---|---|---|
02498758 | Nat-Lanthanum | 2.4069 | 2.4068 |
02287153 | Fosrenol | 2.4068 | 2.4068 |
LU Clinical Criteria
NOEAP Criteria
Therapeutic Class | Reimbursement Criteria |
---|---|
Chronic Renal Failure Drugs – Telephone Request Service (TRS) Drugs | Lanthanum
Sevelamer Hydrochloride
Sevelamer Carbonate
Updated: June 7, 2021
Notes:
Exclusion Criteria: Sevelamer will not be reimbursed in the following cases:
Duration of approval: lifetime On a case-by-case basis, requests may be considered for sevelamer under the EAP for a patient with serum phosphate less than 1.8mmol/L and calcium values less than 2.65 mmol/L. |